Bristol Myers Squibb

NULOJIX

  1. Home
  2.  / 
  3. J Code
  4.  / NULOJIX – J0485

Manufacturer:

Bristol Myers Squibb

Name:

NULOJIX

HCPCS Code Descriptor:

Injection, belatacept, 1 mg

Category:

J Code

HCPCS:

J0485

NDC(s):

00003-0371-13

Primary Type:

Immunosuppressant

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About:

NULOJIX is an Immunosuppressant drug manufactured by Bristol Myers Squibb and administered via the Intravenous route of administration. The J Code: J0485 is aligned to the drug NULOJIX.

Access Pricing and More By Registering

HCPCS Added Date:

1/1/13

HCPCS Effective Date:

1/1/13

HCPCS Short Description:

Belatacept injection

Billing and Coding Guide:

https://www.bmsaccesssupport.bmscustomerconnect.com/servlet/servlet.FileDownload?file=00P1Y000013YV7lUAG

Patient Assistance:

http://www.bmspaf.org

NULOJIX - J0485